FDAnews Announces Launch of Drug Industry Daily
FALLS CHURCH, Va., Sept. 4 /PRNewswire/ -- FDAnews today announced the launch of Drug Industry Daily, an electronic daily briefing that provides coverage of what's happening on Capitol Hill, in the courts and at the FDA, the FTC, HHS, NIH and other key agencies and decision making bodies that affect the pharmaceutical industry. Each issue gives you hard reporting on top issues such as patent exclusivity, DTC advertising, medication errors, program funding, FDA appropriations, bioterrorism, warnings, recalls, approvals and more. "It's never been harder -- or more important -- to keep track of all that's going on and who the players are," said Cynthia A. Carter, publisher of FDAnews. "The drug industry is under fire from many directions, from pricing to safety. Multiple bills are in Congress, countless lawsuits are in the courts and FDA enforcement actions are aimed straight at drug companies' bottom lines." At the same time, developments in drug discovery offer extraordinary opportunities. With so much to keep track of and many contingencies trying to shape the outcome, industry insiders need a reliable source of current developments. Drug Industry Daily delivers the unbiased news every day, so readers get the latest word as the story unfolds, from beginning to end. Lobbyists, government policy makers, industry executives, investment specialists and consultants whose very job is to shape the future of the drug industry use Drug Industry Daily. Anyone who needs to know about developments as they happen will benefit from subscribing. For a limited time, Drug Industry Daily is being offered at an introductory rate of $1,495 per year (a $400 savings off the regular price of $1,895). To become a charter subscriber, phone customer service at +1-703-538-7600 or go to http://www.fdanews.com/pub/did/. Drug Industry Daily is published by FDAnews, publishers of Washington Drug Letter, The Food & Drug Letter, Part 11 Compliance Report, Generic Line, Devices & Diagnostics Letter, Regulatory Watchdog Service, Genomics Newswire and many other information services to help pharmaceutical, biotech and medical device executives meet regulatory and business challenges. MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X01369158
More by this Source
FDAnews Announces FDA's New Generic Drug Safety Labeling Rule Webinar, Dec. 9
Dec 05, 2013, 17:42 ET
FDAnews Announces Leverage Tools for Device CAPA Compliance Virtual Conference, Dec. 19
Dec 03, 2013, 09:01 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.